James Hideo Yamanaka Acquires 20,000 Shares of Organigram (TSE:OGI) Stock

Organigram Holdings Inc. (TSE:OGI) Director James Hideo Yamanaka bought 20,000 shares of Organigram stock in a transaction on Friday, May 22nd. The stock was purchased at an average price of C$1.10 per share, for a total transaction of C$22,000.00. Following the completion of the acquisition, the director owned 20,000 shares in the company, valued at C$22,000. This represents a ∞ increase in their position.

Organigram Trading Up 1.9%

Shares of OGI stock traded up C$0.03 during trading hours on Monday, hitting C$1.59. 131,673 shares of the company were exchanged, compared to its average volume of 219,245. The firm has a market cap of C$223.83 million, a PE ratio of -7.43, a PEG ratio of 0.42 and a beta of 1.72. Organigram Holdings Inc. has a 1 year low of C$1.44 and a 1 year high of C$3.09. The company has a quick ratio of 2.62, a current ratio of 2.82 and a debt-to-equity ratio of 2.20. The firm has a fifty day moving average of C$1.86 and a 200 day moving average of C$2.07.

Analysts Set New Price Targets

Several brokerages have recently weighed in on OGI. ATB Cormark Capital Markets lowered shares of Organigram from a “strong-buy” rating to a “moderate buy” rating and cut their price objective for the stock from C$3.50 to C$3.25 in a report on Wednesday, February 11th. Canaccord Genuity Group set a C$3.00 price objective on shares of Organigram and gave the stock a “buy” rating in a report on Tuesday, January 27th. Two investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the company currently has an average rating of “Buy” and a consensus target price of C$3.13.

Organigram Company Profile

Organigram Inc is a Canadian licensed producer of cannabis products. Organigram focuses on producing exceptional, indoor-grown cannabis for patients and adult recreational consumers, as well as developing global business partnerships.